Theme — Contralateral / Aberrant Lymphatic Drainage
Central question: how often does lymphatic drainage cross to the contralateral side, in melanoma and breast cancer, and why?
Melanoma
- Uren, Howman-Giles and Thompson 2003 - Patterns of Lymphatic Drainage from the Skin in Melanoma — 3,059-patient series; posterior trunk above waist: 30% contralateral / 27% bilateral axillary drainage (≈3% exclusive-contralateral once bilateral cases are separated out) — our best quantitative anchor. Also documents a prior ipsilateral axillary dissection (20 y earlier, for lymphoma) producing an alternative pathway — closest published mechanistic analogue to our case.
- Statius Muller et al 2002 - Unpredictability of Lymphatic Drainage Patterns — companion dataset, same era, triple-technique mapping; dorsal trunk unpredictability 61% (79% below Sappey’s line), independently corroborating Uren et al.
- Chowdhury et al - Truncal Melanoma Contralateral SLN Drainage Prevalence — 14/1308 (1.1%) exclusively contralateral — narrower definition than Uren/Statius Muller above, but the modern (2025), directly comparable cohort study
- Jitworawisut and Tsukuura - Letter on Intraluminal Pressure Hypothesis — proposes obstruction → raised intraluminal pressure → contralateral rerouting; recommends lymphatic US for vessel patency
- Piazzalunga et al 2016 - Melanoma Ambiguous Areas, Two Contralateral SNB Cases — two melanoma case reports, LS+SNB only (no ICG), where LS alone was exclusively/mainly contralateral to clinically obvious disease
- Mondal et al - Muscular Metastasis of Melanoma in Contralateral Limb (BMJ Case Report) — distant/contralateral spread, not nodal; included for context only
Considered and excluded
“Melanoma recurrence in a previously dissected lymph node basin” (PubMed 8129598) — reviewed and excluded: it describes recurrence within the same (ipsilateral) basin, not contralateral spread, so it doesn’t speak to this case’s question. Noted here so it isn’t re-chased later.
Considered and reframed
O’Toole et al 2000 - Aberrant Sentinel Nodes in Malignant Melanoma — the author caught this one: the paper’s “aberrant” means a node found outside any recognised basin (e.g. flank, deltopectoral groove), which by their own definition excludes axillary nodes regardless of laterality. Different phenomenon from our aberrant pathway to a normally-located node. Kept in the vault only as a terminology-contrast reference, not as supporting evidence.
Breast cancer (mechanism proxy — see caveat)
- Goh and Dauway - Synchronous Contralateral Axillary Metastasis (BMJ Case Report)
- CAM in Breast Cancer - IJSCR Case Report (Link Only) — now fully verified. 18-year latency between original ipsilateral axillary surgery and contralateral finding — closest latency match to our case outside melanoma. Also cites Tokmak et al. (2/330, 0.6%, contralateral drainage on lymphoscintigraphy, both with prior SLNB/ALND) and Maaskant-Braat et al.’s meta-analysis: 43.2% aberrant drainage on repeat SLNB in locally recurrent breast cancer — the strongest single number in the vault for “aberrant drainage is common in a re-operative field.”
- Ryu et al - Aberrant Contralateral Axilla Drainage in IBTR
- Sato et al - Altered Lymphatic Drainage Patterns in Re-SLNB (Radiotherapy Effect) — RT correlates with more aberrant drainage (60%→93%)
- Akita et al - Subcutaneous Lymph Flow After Mastectomy
Cross-domain extrapolation
Most of the mechanistic papers above are breast cancer/lymphoedema literature, not melanoma-specific. Useful, since melanoma literature is thin on mechanism, but state explicitly in the Discussion that this is extrapolation, not established melanoma pathophysiology. The Uren et al. 2003 case is the one melanoma-adjacent exception — same mechanism (prior ipsilateral node dissection → new pathway), even if the original indication was lymphoma rather than melanoma.
Still a gap — refined
Melanoma-specific case reports of contralateral axillary nodal involvement remain thin. Piazzalunga et al. helps, but neither of its cases is axilla-to-axilla or decades-prior. O’Toole et al. turned out not to be the same phenomenon. Gingerich et al. (breast cancer) comes closest of all: prior ipsilateral axillary surgery + 18-year latency + contralateral axilla — but no melanoma, no ICG. No source found combines melanoma + prior ipsilateral nodal surgery + multi-decade latency + ICG visualisation of the aberrant channel — that specific combination remains this case’s claim to novelty; the individual pieces each have precedent, just never together.